“new data indicates that the periodic wobble of the jet around the rotation axis did not change during perihelion” ...

Abstract: We establish topological and parametric conditions under which phase angles across three identical impedances can be balanced with small-signal stability guarantees when served from three ...

Nvidia is shifting production capacity to maximize its data center products. Nvidia is resuming sales to China. Rubin architecture will drive a massive spending spree among its clients. When reviewing ...

Modulation advances have fueled more efficient use of bandwidth, although conventional modulation formats still require allowance for upper and lower sidebands around the carrier frequency. Ultra ...

Alphabet's position as an AI infrastructure leader has been in the making for more than a decade. The company's custom AI chips give it a big cost edge. With the most complete AI stack, Alphabet could ...

The biggest stories of the day delivered to your inbox.

Quantum algorithm company Phasecraft Ltd. announced today that it has raised $34 million in new funding to accelerate its work to transform quantum computing’s theoretical promise into practical ...

“Two halves make a whole” is a very old and often true maxim. For example, it’s almost always true when said about AC phase angle power control. You rarely want significant alternating half-cycle ...

This work investigated how various indicators of muscle quality, mass, and strength were related to cognitive parameters in middle-aged and older adults. The results showed that phase angle—an ...

Like any big industry, the automotive business has several dumpsters filled with products and ideas that should have remained conceptual. From modern climate controls buried within successive ...

Development of both the prostate cancer androgen receptor assay and the multi-cancer DDR micronuclei assay successfully completed for AstraZeneca Results of Eisai Phase 2 pilot study supports the ...

DEDHAM, Mass.--(BUSINESS WIRE)--Qlaris Bio, Inc., a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced positive topline results from two ...